Corbus Pharmaceuticals Holdings Inc. (CRBP)

6.35
0.30 4.51
NASDAQ : Health Technology
Prev Close 6.65
Open 6.60
Day Low/High 6.20 / 6.70
52 Wk Low/High 5.30 / 9.96
Volume 436.79K
Avg Volume 848.20K
Exchange NASDAQ
Shares Outstanding 57.14M
Market Cap 379.98M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Corbus Pharmaceuticals Holdings Stock Sees Short Interest Make 22.7% Move

Corbus Pharmaceuticals Holdings Stock Sees Short Interest Make 22.7% Move

The most recent short interest data has been released for the 02/15/2018 settlement date, which shows a 1,617,885 share increase in total short interest for Corbus Pharmaceuticals Holdings Inc , to 8,757,760, an increase of 22.66% since 01/31/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trimming a Semiconductor Name

At the same time we are raising Pixelworks' price target to $8 from $6.50.

Keep Buying Pot Stocks; Weed Isn't Going Away

Keep Buying Pot Stocks; Weed Isn't Going Away

Selloffs like the one in marijuana stocks present entry points, if this is your cup of tea.

Interesting CRBP Put And Call Options For February 16th

Interesting CRBP Put And Call Options For February 16th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

Trimming a Biotech; Adding 2 Bullpen Names

We'll sell some Inovio Pharma on recent strength and put 2 'pot names,' Kush Bottles and Corbus Pharmaceuticals, in the Bullpen.

How to Invest in America's Legal Weed Trend Through Marijuana Stocks

How to Invest in America's Legal Weed Trend Through Marijuana Stocks

Recreational use of marijuana is now legal in California, but don't get lost among the weeds of stocks.

California Dreamin': Searching for a 'Pot' of Gold Through Marijuana Stocks

California Dreamin': Searching for a 'Pot' of Gold Through Marijuana Stocks

On Monday, recreational use of marijuana will be legal in California, so let's visit 3 weed stocks.

Short Interest Makes 10.4% Move For CRBP

Short Interest Makes 10.4% Move For CRBP

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 658,457 share increase in total short interest for Corbus Pharmaceuticals Holdings Inc , to 6,968,817, an increase of 10.43% since 10/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting CRBP Put And Call Options For December 15th

Interesting CRBP Put And Call Options For December 15th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

Commit To Purchase Corbus Pharmaceuticals Holdings At $5, Earn 15.4% Annualized Using Options

Commit To Purchase Corbus Pharmaceuticals Holdings At $5, Earn 15.4% Annualized Using Options

Investors eyeing a purchase of Corbus Pharmaceuticals Holdings Inc stock, but tentative about paying the going market price of $6.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2018 put at the $5 strike, which has a bid at the time of this writing of 40 cents.

Commit To Buy Corbus Pharmaceuticals Holdings At $5, Earn 17.2% Annualized Using Options

Commit To Buy Corbus Pharmaceuticals Holdings At $5, Earn 17.2% Annualized Using Options

Investors considering a purchase of Corbus Pharmaceuticals Holdings Inc stock, but tentative about paying the going market price of $6.42/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $5 strike, which has a bid at the time of this writing of 25 cents.

Oversold Conditions For Corbus Pharmaceuticals Holdings (CRBP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Did Corbus Investors Get Thrown Off by a Red Herring?

Did Corbus Investors Get Thrown Off by a Red Herring?

Investors ran for the exits after analysts pointed out that glowing Phase 2 study results for Corbus actually weren't that great. But a better story lies behind this biotech play.

Home Depot, Federal Realty, more: 'Mad Money' Lightning Round

Home Depot, Federal Realty, more: 'Mad Money' Lightning Round

Jim Cramer is bullish on Home Depot, Corbus Pharmaceuticals, Federal Realty and Vector Group.

Market Stays Strong in the Fight: Cramer's 'Mad Money' Recap (Friday 4/7/17)

Market Stays Strong in the Fight: Cramer's 'Mad Money' Recap (Friday 4/7/17)

Even with a trifecta of worries, stocks hold tight thanks to decisive U.S. action in Syria, says Jim Cramer.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Corbus Pharmaceuticals Holdings, Inc.

Levi & Korsinsky announces it has commenced an investigation of Corbus Pharmaceuticals Holdings, Inc.

Taser, AMD, Amgen, Old Republic :'Mad Money' Lightning Round (3/30/17)

Taser, AMD, Amgen, Old Republic :'Mad Money' Lightning Round (3/30/17)

Why Jim Cramer likes Taser, Advanced Micro Devices, Amgen and more.

Busting the Shorts : Cramer's 'Mad Money' Recap (Thursday 3/30/17)

Busting the Shorts : Cramer's 'Mad Money' Recap (Thursday 3/30/17)

This month's resilience in the market has a lot to do with short squeezes in big tech names.

Corbus Pharma Drug Shows No Clinical Benefit for Cystic Fibrosis Patients

Corbus Pharma Drug Shows No Clinical Benefit for Cystic Fibrosis Patients

Corbus Pharmaceuticals waves a sea of hands in front of investors' eyes Thursday to obscure dismal results from another mid-stage study of its experimental anti-inflammatory drug anabasum.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Interesting CRBP Put And Call Options For October 20th

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the October 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

A Few Names on my Radar on This Softness

A Few Names on my Radar on This Softness

The indices may test intraday lows, which we haven't seen at this point in the day in a very long time.

First Week of March 17th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

First Week of March 17th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

Investors in Corbus Pharmaceuticals Holdings Inc saw new options begin trading this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Corbus Pharmaceuticals Looks to Be a Winner, While Pershing Gold Requires Patience

Corbus Pharmaceuticals Looks to Be a Winner, While Pershing Gold Requires Patience

Technical analysis of four stocks that could produce big rallies but carry risks shows different outlooks.

Here Are 4 Somewhat Risky Stocks That May Deliver Explosive Gains

Here Are 4 Somewhat Risky Stocks That May Deliver Explosive Gains

Although these companies lack the brawn of, say, Apple, their shares have the potential for big increases for those who are willing to place a bet.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

First Week of CRBP February 2017 Options Trading

First Week of CRBP February 2017 Options Trading

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals

Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals

Positive results mean a lot for HD and CRBP, says Jim Cramer.

TheStreet Quant Rating: D (Sell)